15th Jun 2021

Top EU court bans stem cell patents

The European Court of Justice on Tuesday (18 October) banned patents on stem cells extracted from human embryos that are then discarded, a ruling with wide-reaching implications for medical research in Europe.

In accordance with EU law, patents have to be excluded from any areas "where respect for human dignity could be affected," the court said in its verdict. The use of human embryo cells can only be for "therapeutic or diagnostic purposes" applied to the embryo itself, but "not for scientific purposes."

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

  • Stem cells cannot be used if the embryo is killed (Photo: BWJones)

"A process which involves removal of a stem cell from a human embryo ... entailing the destruction of that embryo, cannot be patented," the ruling reads.

The case was brought by German scientist Oliver Bruestle, who in 1997 patented a method of using stem cells from human embryos to treat patients with Parkinson's disease. His patent was challenged by Greenpeace in German courts, which in turn asked for legal advice from the EU's top court.

"This unfortunate ruling wipes out years of transnational research by European researchers in one fell swoop," said Bruestle, a professor at Bonn University. He said the old continent will fall behind other parts of the world where such practices are not restricted.

Religious groups, such as the commission of European bishops (Comece), welcomed the verdict as a "milestone in the protection of human life in EU legislation." The organisation said EU science research should focus on adult stem cells or cells from umbilical cord blood.

"These methods enjoy wide acceptance both on scientific and ethical grounds," the bishops said.

Greenpeace also welcomed the decision, noting that it will prevent biotech companies from turning a profit from human life.

“By blocking the patenting and commercialization of human embryos the European Court of Justice has today strengthened the protection of human life against commercial interests within the EU", said Lasse Bruun, a Greenpeace campaigner on the issue.

The EU patent office had stopped granting patents on human embryo cells in 2006, but national patent offices did not change their practice. This will have to change following the ECJ ruling.

Bruun noted, however, that "the decision will affect stem cell research only partially, as in recent years, researchers have found several alternative methods for obtaining stem cells, without the need to destroy human embryos."

EU to continue to fund stem cell research

The EU has agreed to continue its funding for stem cell research after a lengthy debate convinced a broad majority of the bloc's member states to agree on a new research package for the next seven years.

Embryonic stem cell research divides MEPs

European lawmakers are set to endorse a new plan to finance research from 2007-13, but MEPs are still divided over the ethical issue of whether or not to continue funding research using embryonic stem cells.

Member states squabble over seat of EU patent tribunal

EU ministers have failed to agree on the seat and the funding of a unified patent court, with Paris, London and Munich fighting for the headquarters. Italy, meanwhile, has indicated it may join the 25-strong scheme, leaving only Spain out.

News in Brief

  1. BBC and others boycott Belarus press circus
  2. Report: EU and US to unveil aircraft subsidy truce
  3. Putin refuses to guarantee Navalny will survive jail
  4. Erdoğan agrees to pull out mercenaries from Libya
  5. EU starts sale of first bonds for Covid-19 recovery fund
  6. Germans told not to 'storm pharmacies' for Covid pass
  7. Indonesia warns Covid-19 wave may not peak until July
  8. WTO chief: 'drop trade barriers on Covid-19 treatments'


Sweden's non-lockdown didn't work - why not?

The Swedish king would have been better advised to use his annual Christmas interview to call for unity of purpose and shed light on the political roots of the country's response.


BioNTech: Stop talking about their 'migration background'

I understand that the German-Turkish community - often subjected to condescension in Germany - celebrated the story. Uğur Şahin and Özlem Türecki represent scientific excellence and business success at the highest level.

Stakeholders' Highlights

  1. Nordic Council of MinistersNineteen demands by Nordic young people to save biodiversity
  2. Nordic Council of MinistersSustainable public procurement is an effective way to achieve global goals
  3. Nordic Council of MinistersNordic Council enters into formal relations with European Parliament
  4. Nordic Council of MinistersWomen more active in violent extremist circles than first assumed
  5. Nordic Council of MinistersDigitalisation can help us pick up the green pace
  6. Nordic Council of MinistersCOVID19 is a wake-up call in the fight against antibiotic resistance

Latest News

  1. China officially joins Russia as a danger to Nato
  2. German Greens face reality check amid CDU gains
  3. EU Parliament wants Europe to take lead on sea-rescues
  4. MEPs urged to end gas-funding, fix cross-border projects rules
  5. Biden in Brussels - what's in the 'in-tray'?
  6. Yemen foreign minister to EU: to stop the war, talk to Iran
  7. Brexit grumbles overshadow UK summit
  8. Former French PM to work for Russian oil firm

Join EUobserver

Support quality EU news

Join us